Dietary supplements of phenylalanine have been fed previously to experimental animals in an attempt to simulate the human metabolic disorder phenylketonuria. In the present study the effects of several of these supplements were compared. Weanling female rats were fed a diet supplemented with excess L- or DL-phenylalanine. Plasma phenylalanine levels were elevated by one week and varied with the quantity of that amino acid in the diet. Additional supplements of L-tryptophan reduced, and L-tyrosine elevated, plasma phenylalanine levels. After 3, 6, and 12 weeks, plasma phenylalanine levels decreased in several dietary groups, but did not reach normal levels. Five per cent DL-phenylalanine supplementation was not associated with growth failure or increased mortality. Growth failure was produced by an equal supplement of the L-isomer and other diets which contained 5% phenylalanine in conjunction with excess tyrosine or tryptophan. Surviving females were bred following 12 weeks of study. Although the diets did not interfere with conception and pregnancy, most rats were unable to rear more than 30% of their litter. Hepatic phenylalanine hydroxylase activity was depressed, and the activity varied directly with growth and indirectly with plasma phenylalanine levels. The most appropriate dietary supplement for investigating the effects of hyperphenylalaninemia will depend upon the design of the experiment, permissible mortality rates and the plasma phenylalanine levels required.